ProfileOfResearchers

Identificadas 5

1

TÃTULO: Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
AUTORES: Bellini, Angela; Poetschger, Ulrike; Bernard, Virginie; Lapouble, Eve; Baulande, Sylvain; Ambros, Peter F.; Auger, Nathalie; Beiske, Klaus; Bernkopf, Marie; Betts, David R.; Bhalshankar, Jaydutt; Bown, Nick; de Preter, Katleen; Clement, Nathalie; Combaret, Valerie; de Mora, Jaime Font; George, Sally L.; Jimenez, Irene; Jeison, Marta; Marques, Barbara; Martinsson, Tommy; Mazzocco, Katia; Morini, Martina; Muehlethaler Mottet, Annick; Noguera, Rosa; Pierron, Gaelle; Rossing, Maria; Taschner Mandl, Sabine; Van Roy, Nadine; Vicha, Ales; Chesler, Louis; Balwierz, Walentyna; Castel, Victoria; Elliott, Martin; Kogner, Per; Laureys, Genevieve; Luksch, Roberto; Malis, Josef; Popovic Beck, Maja; Ash, Shifra; Delattre, Olivier; Valteau Couanet, Dominique; Tweddle, Deborah A.; Ladenstein, Ruth; Schleiermacher, Gudrun; ...Mais
PUBLICAÇÃO: 2021, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 39, NÚMERO: 30

INDEXADO EM:

WOS

2

TÃTULO: Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group
AUTORES: Inge M Ambros; Gian Paolo Tonini; Ulrike Poetschger; Nicole Gross; Veronique Mosseri; Klaus Beiske; Ana P Berbegall; Jean Benard; Nick Bown; Huib Caron; Valerie Combaret; Jerome Couturier; Raffaella Defferrari; Olivier Delattre; Marta Jeison; Per Kogner; John Lunec; Barbara Marques; Tommy Martinsson; Katia Mazzocco; Rosa Noguera; Gudrun Schleiermacher; Alexander Valent; Nadine Van Roy; Eva Villamon; Dasa Janousek; Ingrid Pribill; Evgenia Glogova; Edward F Attiyeh; Michael D Hogarty; Tom F Monclair; Keith Holmes; Dominique Valteau Couanet; Victoria Castel; Deborah A Tweddle; Julie R Park; Sue Cohn; Ruth Ladenstein; Maja Beck Popovic; Bruno De Bernardi; Jean Michon; Andrew D J Pearson; Peter F Ambros; ...Mais
PUBLICAÇÃO: 2020, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 38, NÚMERO: 31

INDEXADO EM:

Scopus

WOS

3

TÃTULO: Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial Full Text
AUTORES: Ruth Ladenstein; Ulrike Poetschger; Andrew D J Pearson; Penelope Brock; Roberto Luksch; Victoria Castel; Isaac Yaniv; Vassilios Papadakis; Genevieve Laureys; Josef Malis; Walentyna Balwierz; Ellen Ruud; Per Kogner; Henrik Schroeder; Ana Forjaz de Lacerda; Maja Beck Popovic; Pavel Bician; Miklos Garami; Toby Trahair; Adela Canete; Peter F Ambros; Keith Holmes; Mark Gaze; Guenter Schreier; Alberto Garaventa; Gilles Vassal; Jean Michon; Dominique Valteau Couanet; ...Mais
PUBLICAÇÃO: 2017, FONTE: LANCET ONCOLOGY, VOLUME: 18, NÚMERO: 4

INDEXADO EM:

WOS

4

TÃTULO: MAJOR RESULTS FROM THE HR-NBL1/SIOPEN TRIAL FOR HIGH RISK NEUROBLASTOMA Full Text
AUTORES: Ruth Ladenstein; Ulrike Poetschger; Roberto Luksch; Penelope Brock; Victoria Castel; Isaac Yaniv; Vassilios Papadakis; Genevieve Laureys; Josef Malis; Walentyna Balwierz; Ellen Ruud; Per Kogner; Henrik Schroeder; Ana Forjaz De Lacerda; Maja Beck Popovic; Pavel Bician; Miklos Garami; Toby Trahair; Peter Ambros; Andrew D J Pearson; Dominique Valteau Couanet; ...Mais
PUBLICAÇÃO: 2012, FONTE: PEDIATRIC BLOOD & CANCER, VOLUME: 59, NÚMERO: 6

INDEXADO EM:

WOS

5

TÃTULO: Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study
AUTORES: Ruth Ladenstein; Dominique Valteau Couanet; Penelope Brock; Isaac Yaniv; Victoria Castel; Genevieve Laureys; Josef Malis; Vassilios Papadakis; Ana Lacerda; Ellen Ruud; Per Kogner; Miklos Garami; Walentyna Balwierz; Henrik Schroeder; Maja Beck Popovic; Guenter Schreier; David Machin; Ulrike Potschger; Andrew Pearson;
PUBLICAÇÃO: 2010, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 28, NÚMERO: 21

INDEXADO EM:

WOS

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service